Seminars in Ultrasound, CT and MRI
Volume 30, Issue 5 , Pages 418-425 , October 2009

Liver Masses With Central or Eccentric Scar

  • Tonsok Kim, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Tonsok Kim, MD, PhD, Department of Radiology, Osaka University, Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
    • ,
  • Masatoshi Hori, MD, PhD
    • ,
  • Hiromitsu Onishi, MD, PhD

References 

  1. Blachar A, Federle MP, Ferris JV, et al. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002;223:532–539
  2. International Working Party. Terminology of nodular hepatocellular lesions. J Hepatol. 1995;22:983–993
  3. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol. 2006;58:236–245
  4. Fukukura Y, Nakashima O, Kusaba A, et al. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol. 1998;29:470–473
  5. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. J Hepatol. 1985;5:1194–1200
  6. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–1454
  7. Brancatelli G, Federle MP, Grazioli L, et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology. 2001;219:61–68
  8. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts, in Armed Forces Institute of Pathology (ed): Atlas of Tumor Pathology, Second Series Fascicle. In: Washington, DC: Armed Forces Institute of Pathology; 1989;p. 26;7
  9. Carlson SK, Johnson CD, Bender CE, et al. Of focal nodular hyperplasia of the liver. AJR Am J Roentgenol. 2000;174:705–712
  10. Morteĺe KJ, Praet M, Van Vlierberghe H, et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: Radiologic–pathologic correlation. AJR Am J Roentgenol. 2000;175:687–692
  11. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: Findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics. 2004;24:3–19
  12. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–1454
  13. Shamsi K, de Schepper A, Degryse H, et al. Focal nodular hyperplasia of the liver: Radiologic findings. Abdom Imaging. 1993;18:32–38
  14. Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma: Differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol. 2008;190:58–66
  15. Ungermann L, Eliás P, Zizka J, et al. Focal nodular hyperplasia: Spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol. 2007;63:290–294
  16. Filippone A, Basilico R, Di FF. Focal nodular hyperplasia. In:  Lencioni R,  Cioni D,  Bartolozzi C editor. Focal Liver Lesions. Berlin, Heidelberg: Springer-Verlag; 2005;p. 119–135
  17. Shirkhoda A, Farah MC, Bernacki E, et al. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging. 1994;19:34–38
  18. Buetow PC, Pantongrag-Brown L, Buck JL, et al. Focal nodular hyperplasia of the liver: Radiologic-pathologic correlation. Radiographics. 1996;16:369–388
  19. Vilgrain V, Fléjou JF, Arrivé L, et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology. 1992;184:1–6
  20. Kehagias D, Moulopoulos L, Antoniou A, et al. Focal nodular hyperplasia: Imaging findings. Eur Radiol. 2001;11:202–212
  21. Ba-Ssalamah A, Schima W, Schmook MT, et al. Atypical focal nodular hyperplasia of the liver: Imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol. 2002;179:1447–1456
  22. Grazioli L, Morana G, Kirchin MA, et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: Prospective study. Radiology. 2005;236:166–177
  23. Adam YG, Harvos AJ, Fortner JG. Giant hemangiomas of the liver. Ann Surg. 1970;172:239–245
  24. Elsayes KM, Narra VR, Yin Y, et al. Focal hepatic lesions: Diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics. 2005;25:1299–1320
  25. Choi BI, Han MC, Park JH, et al. Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases. AJR Am J Roentgenol. 1989;152:1221–1226
  26. Ichikawa T, Federle MP, Grazioli L, et al. Fibrolamellar hepatocellular carcinoma: Imaging and pathologic findings in 31 recent cases. Radiology. 1999;213:352–361
  27. McLarney JK, Rucker PT, Bender GN, et al. Fibrolamellar carcinoma of the liver: Radiologic-pathologic correlation. Radiographics. 1999;19:453–471
  28. Friedman AC, Lichtenstein JE, Goodman ZD, et al. Fibrolamellar hepatocellular carcinoma. Radiology. 1985;157:583–587
  29. Blachar A, Federle MP, Ferris JV, et al. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002;223:532–539
  30. Brandt DJ, Johnson CD, Stephens DH, et al. Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol. 1988;151:295–299
  31. Corrigan K, Semelka RC. Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging. 1995;20:122–125
  32. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer. 2001;94:153–156
  33. Barazani Y, Hiatt JR, Tong MJ, et al. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31:1243–1248
  34. Stevens WR, Johnson CD, Stephens DH, et al. Findings in hepatocellular carcinoma: Correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology. 1994;191:531–537
  35. Yamamoto M, Ariizumi S, Yoshitoshi K, et al. Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance. Surg Oncol. 2006;94:587–591
  36. Choi D, Kim SH, Lim J, et al. Preoperative detection of hepatocellular carcinoma Ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol. 2001;176:475–482
  37. Saito K, Kotake F, Ito N, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: Quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4:1–9
  38. Soyer P, Bluemke DA, Sibert A, et al. MR imaging of intrahepatic cholangiocarcinoma. Abdom Imaging. 1995;20:126–130
  39. Honda H, Onitsuka H, Yasumori K, et al. Intrahepatic peripheral cholangiocarcinoma: Two-phased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr. 1993;17:397–402
  40. Soyer P, Bluemke DA, Vissuzaine C, et al. CT of hepatic tumors: Prevalence and specificity of retraction of the adjacent capsule. AJR Am J Roentgenol. 1994;162:1119–1122
  41. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma (1. Peripheral cholangiocarcinoma). AJR Am J Roentgenol. 1995;165:1427–1431
  42. Fan ZM, Yamashita Y, Harada M, et al. Intrahepatic cholangiocarcinoma: spin echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol. 1993;161:313–317
  43. Giovanoli O, Heim M, Terracciano L, et al. MRI of hepatic adenomatosis: Initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol. 2008;190:W290–W293
  44. Kim KA, Kim KW, Park SH, et al. Unusual mesenchymal liver tumors in adults: Radiologic–pathologic correlation. AJR Am J Roentgenol. 2006;187:W481–W489

PII: S0887-2171(09)00060-2

doi: 10.1053/j.sult.2009.07.004

Seminars in Ultrasound, CT and MRI
Volume 30, Issue 5 , Pages 418-425 , October 2009

Article Tools

* Image Usage & Resolution